COVID-19

Bergenbio Reports Results of Bemcentinib in P-II (ACCORD2) Study for the Treatment of COVID-19

Bergenbio Reports Results of Bemcentinib in P-II (ACCORD2) Study for the Treatment of COVID-19

Shots: The P-II (ACCORD2) study evaluates bemcentinib + SoC vs SoC alone in hospit...

Shionogi Presents Results of S-217622 in P-IIb Study for the Treatment of COVID-19 at ECCMID 2022

Shionogi Presents Results of S-217622 in P-IIb Study for the Treatment of COVID-19 at ECCMID 2022

Shots: The P-IIb results from the P-II/III trial evaluating S-217622 (qd for 5 day...

Image